Azenta Management

Management Kriterienprüfungen 1/4

Azenta's CEO ist Steve Schwartz , ernannt in Oct 2010, hat eine Amtszeit von 13.67 Jahren. Die jährliche Gesamtvergütung beträgt $5.55M , bestehend aus 13.5% Gehalt und 86.5% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.75% der Aktien des Unternehmens, im Wert von €20.55M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.1 Jahre bzw. 2 Jahre.

Wichtige Informationen

Steve Schwartz

Geschäftsführender

US$5.6m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	13.5%
Amtszeit als Geschäftsführer	13.7yrs
Eigentum des Geschäftsführers	0.8%
Durchschnittliche Amtszeit des Managements	5.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	2yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Steve Schwartz im Vergleich zu den Einnahmen von Azenta verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	n/a	n/a	-US$152m
Dec 31 2023	n/a	n/a	-US$17m
Sep 30 2023	US$6m	US$750k	-US$13m
Jun 30 2023	n/a	n/a	-US$21m
Mar 31 2023	n/a	n/a	-US$26m
Dec 31 2022	n/a	n/a	-US$25m
Sep 30 2022	US$5m	US$742k	-US$11m
Jun 30 2022	n/a	n/a	-US$28m
Mar 31 2022	n/a	n/a	-US$23m
Dec 31 2021	n/a	n/a	-US$29m
Sep 30 2021	US$5m	US$712k	-US$29m
Jun 30 2021	n/a	n/a	-US$69m
Mar 31 2021	n/a	n/a	-US$53m
Dec 31 2020	n/a	n/a	-US$37m
Sep 30 2020	US$4m	US$675k	-US$26m
Jun 30 2020	n/a	n/a	US$41m
Mar 31 2020	n/a	n/a	US$28m
Dec 31 2019	n/a	n/a	US$16m
Sep 30 2019	US$4m	US$668k	-US$61m
Jun 30 2019	n/a	n/a	US$3m
Mar 31 2019	n/a	n/a	US$7m
Dec 31 2018	n/a	n/a	US$72m
Sep 30 2018	US$4m	US$644k	US$68m
Jun 30 2018	n/a	n/a	US$35m
Mar 31 2018	n/a	n/a	US$47m
Dec 31 2017	n/a	n/a	-US$2m
Sep 30 2017	US$4m	US$625k	US$11m

Vergütung im Vergleich zum Markt: SteveDie Gesamtvergütung ($USD5.55M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt German ($USD2.27M).

Entschädigung vs. Einkommen: SteveDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.

Geschäftsführer

Steve Schwartz (65 yo)

13.7yrs

Amtszeit

US$5,554,462

Vergütung

Dr. Stephen S. Schwartz, also known as Steve, was a Director Azenta US, Inc until May 2024. He is President and Chief Executive Officer at Azenta US, Inc. He has been Chief Executive Officer of Azenta, Inc...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Stephen Schwartz	CEO & President	13.7yrs	US$5.55m	0.75% $ 20.8m
Robin Vacha	Senior Vice President of Global Operations	no data	US$1.43m	0.044% $ 1.2m
Jason Joseph	Senior VP	13.3yrs	US$1.44m	0.17% $ 4.8m
Herman Cueto	Executive VP & CFO	less than a year	keine Daten	keine Daten
Violetta Hughes	VP & Chief Accounting Officer	less than a year	keine Daten	0% $ 0
Michael Paulo	VP and Chief Information & Digital Officer	6.9yrs	keine Daten	keine Daten
John O'Brien	Senior Vice President of Corporate Development	14.1yrs	keine Daten	keine Daten
Olga Pirogova	Senior VP & Chief HR Officer	less than a year	keine Daten	keine Daten
J. Woodward	Senior Vice President of Global Quality & Regulatory	14.6yrs	keine Daten	keine Daten
Ginger Zhou	Senior VP & GM of Multiomics and Synthesis Solutions	5.1yrs	keine Daten	0.016% $ 434.7k
David Wang	Senior VP & GM of Sample Management Solutions	1.4yrs	keine Daten	0.0099% $ 273.5k
Luc Provost	VP & CEO of B Medical Systems	less than a year	keine Daten	keine Daten

5.1yrs

Durchschnittliche Betriebszugehörigkeit

52yo

Durchschnittliches Alter

Erfahrenes Management: BA3Das Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.1 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Tina Nova	Independent Director	1.4yrs	US$207.50k	0.011% $ 311.4k
Michael Rosenblatt	Independent Director	5.8yrs	US$260.00k	0.024% $ 668.9k
Martin Madaus	Independent Director	less than a year	keine Daten	0.0046% $ 126.4k
Didier Hirsch	Independent Director	less than a year	keine Daten	0.0046% $ 126.4k
Edward Bousa	Independent Director	less than a year	keine Daten	0.0046% $ 126.4k
Robyn Davis	Independent Vice Chair of the Board	11yrs	US$278.75k	0.055% $ 1.5m
Erica McLaughlin	Independent Director	4.2yrs	US$273.75k	0.024% $ 657.3k
Frank Casal	Independent Chairman	2.6yrs	US$275.00k	0.017% $ 481.7k

2.0yrs

Durchschnittliche Betriebszugehörigkeit

67.5yo

Durchschnittliches Alter

Erfahrener Vorstand: BA3Die Vorstandsmitglieder gelten nicht als erfahren ( 2 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.

Azenta Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

Stephen Schwartz to Retire as CEO of Azenta, Inc

High number of new directors

Ellen M. Zane Decides Not to Stand for Election to the Board of Directors of Azenta, Inc

Azenta, Inc., Annual General Meeting, Jan 30, 2024

Azenta, Inc. Announces Chief Financial Officer Changes, Effective October 16, 2023

Insider recently sold €369k worth of stock

Recent updates

Azenta, Inc. Provides Earnings Guidance for the Full Fiscal Year 2024

Second quarter 2024 earnings released: US$2.47 loss per share (vs US$0.029 loss in 2Q 2023)

Stephen Schwartz to Retire as CEO of Azenta, Inc

Now 22% overvalued

Azenta, Inc. to Report Q2, 2024 Results on May 08, 2024

Now 21% overvalued

New major risk - Revenue and earnings growth

New minor risk - Profitability

High number of new directors

Azenta, Inc. Announces the Launch of the BioArc Ultra

Azenta, Inc. to Report Q1, 2024 Results on Feb 07, 2024

Azenta, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Ellen M. Zane Decides Not to Stand for Election to the Board of Directors of Azenta, Inc

Azenta, Inc., Annual General Meeting, Jan 30, 2024

Azenta, Inc. Provides Earnings Guidance for the Full Year Fiscal 2024

Full year 2023 earnings released: US$0.19 loss per share (vs US$0.15 loss in FY 2022)

Azenta, Inc. to Report Q4, 2023 Results on Nov 13, 2023

Politan Capital Provides Information to the Shareholders

Azenta, Inc. Announces Chief Financial Officer Changes, Effective October 16, 2023

Politan Capital Management Engages in Discussions with Azenta

Politan Capital Management Engages in Discussions with Azenta

New minor risk - Insider selling

Insider recently sold €369k worth of stock

Third quarter 2023 earnings released: US$0.039 loss per share (vs US$0.094 loss in 3Q 2022)

Azenta, Inc. Revises Revenue Guidance for the Full Year of 2023

Azenta, Inc. to Report Q3, 2023 Results on Aug 08, 2023

Forecast breakeven date pushed back to 2025

Second quarter 2023 earnings released: US$0.029 loss per share (vs US$0.024 loss in 2Q 2022)

Azenta, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal Year 2023

Azenta, Inc. to Report Q2, 2023 Results on May 09, 2023

First quarter 2023 earnings released: US$0.15 loss per share (vs US$0.038 profit in 1Q 2022)

Azenta, Inc. Provides Earnings Guidance for the Second Quarter of Fiscal Year 2023

Azenta, Inc. to Report Q1, 2023 Results on Feb 08, 2023

Azenta, Inc. (NasdaqGS:AZTA) acquired Ziath Ltd.

Azenta, Inc. Announces Election of Directors

Azenta, Inc., Annual General Meeting, Jan 31, 2023

Full year 2022 earnings released: US$0.15 loss per share (vs US$0.39 loss in FY 2021)

Azenta Announces Board Resignations

Azenta, Inc. to Report Q4, 2022 Results on Nov 14, 2022

Azenta, Inc. Announces Matthew McManus Would No Longer Serve as the Companys Chief Operating Officer Effective as of October 14, 2022

Azenta, Inc. (NasdaqGS:AZTA) acquired B Medical Systems S.à R.L. from Navis Capital Partners.

Executive VP & COO recently bought €500k worth of stock

Third quarter 2022 earnings released: US$0.094 loss per share (vs US$0.53 profit in 3Q 2021)

Azenta, Inc. Provides Earnings Guidance for the Fourth Quarter Fiscal 2022

Azenta, Inc. (NasdaqGS:AZTA) entered into an agreement to acquire B Medical Systems S.à R.L. for approximately €460 million.

Azenta, Inc. Provides Earnings Guidance for the Third Fiscal Quarter Ended June 30, 2022

Azenta, Inc.(NasdaqGS:AZTA) dropped from Russell 3000E Growth Index

Azenta, Inc. announced delayed 10-Q filing

Second quarter 2022 earnings released: US$0.024 loss per share (vs US$0.32 profit in 2Q 2021)

Azenta, Inc. Provides Revenue Guidance for the Third Quarter of 2022

Now 21% undervalued after recent price drop

Azenta, Inc. to Report Q2, 2022 Results on May 03, 2022

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Azenta, Inc. Provides Earnings Guidance for the Second Quarter Fiscal Year 2022

Azenta, Inc. Announces Executive Changes

Forecast breakeven date pushed back to 2023

Azenta, Inc.(NasdaqGS:AZTA) dropped from NASDAQ Composite Index

Upcoming dividend of US$0.10 per share

Independent Director recently sold €282k worth of stock

Full year 2021 earnings released: US$0.39 loss per share (vs US$0.88 profit in FY 2020)

Insufficient new directors

Insufficient new directors

Brooks Automation, Inc. Introduces Azenta Life Sciences to Advance Innovative Sample Solutions

Investor sentiment improved over the past week

Upcoming dividend of US$0.10 per share

Brooks Automation, Inc. Provides Earnings Guidance for the Fourth Quarter of Fiscal 2021

Third quarter 2021 earnings released: EPS US$0.53 (vs US$0.19 in 3Q 2020)

Brooks Automation, Inc.(NasdaqGS:BRKS) dropped from Russell 2000 Dynamic Index

Upcoming dividend of US$0.10 per share